Long-term Outcomes of Open Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer in the Prostate-specific Antigen Era EDITORIAL COMMENT

被引：0
作者：
Nelson, Joel B. [1 ]
机构：
[1] Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15260 USA
来源：
UROLOGY | 2012年 / 79卷 / 03期
关键词：
D O I：
10.1016/j.urology.2011.10.048
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：631 / 632
页数：3
相关论文
共 50 条
[21]   Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer [J].
Han, M ;
Partin, AW ;
Zahurak, M ;
Piantadosi, S ;
Epstein, JI ;
Walsh, PC .
JOURNAL OF UROLOGY, 2003, 169 (02) :517-523
[22]   OVERALL AND CANCER SPECIFIC SURVIVAL FOLLOWING DEFINITIVE THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER IN THE PROSTATE-SPECIFIC ANTIGEN ERA [J].
Stephenson, Andrew ;
Klein, Eric ;
Ciezki, Jay ;
Reddy, Chandana ;
Kattan, Michael ;
Yu, Changhong ;
Deasy, Joseph ;
Michalski, Jeff ;
Kallogjeri, Donna ;
Lubahn, Jessica ;
Luly, Jason ;
Piccirillo, Jay ;
Kibel, Adam .
JOURNAL OF UROLOGY, 2010, 183 (04) :E113-E113
[23]   Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical 14 retropubic prostatectomy for localized prostate cancer? [J].
Haukaas, SA ;
Halvorsen, OJ ;
Daehlin, L ;
Hostmark, J ;
Akslen, LA .
BJU INTERNATIONAL, 2006, 97 (01) :51-55
[24]   Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era [J].
Boorjian, Stephen A. ;
Thompson, R. Houston ;
Siddiqui, Sameer ;
Bagniewski, Stephanie ;
Bergstralh, Erik J. ;
Karnes, R. Jeffrey ;
Frank, Igor ;
Blute, Michael L. .
JOURNAL OF UROLOGY, 2007, 178 (03) :864-870
[25]   Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomy [J].
Stephan, C ;
Jung, K ;
Brux, B ;
Lein, M ;
Sinha, P ;
Schnorr, D ;
Leoning, SA .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (04) :309-311
[26]   Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era [J].
Stephenson, Andrew J. ;
Kattan, Michael W. ;
Eastham, James A. ;
Klein, Eric A. ;
Bianco, Fernando J. ;
Vickers, Andrew J. ;
Yossepowitch, Ofer ;
Scardino, Peter T. .
JOURNAL OF UROLOGY, 2008, 179 (04) :649-649
[27]   Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era [J].
Stephenson, Andrew J. ;
Kattan, Michael W. ;
Eastham, James A. ;
Bianco, Fernando J., Jr. ;
Yossepowitch, Ofer ;
Vickers, Andrew J. ;
Klein, Eric A. ;
Wood, David P. ;
Scardino, Peter T. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4300-4305
[28]   Prostate-specific antigen after anatomic radical retropubic prostatectomy - Patterns of recurrence and cancer control [J].
Pound, CR ;
Partin, AW ;
Epstein, JI ;
Walsh, PC .
UROLOGIC CLINICS OF NORTH AMERICA, 1997, 24 (02) :395-&
[29]   The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy [J].
Melchior, SW ;
Noteboom, J ;
Gillitzer, R ;
Lange, PH ;
Blumenstein, BA ;
Vessella, RL .
BJU INTERNATIONAL, 2001, 88 (03) :221-225
[30]   Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer [J].
Kupelian, P ;
Katcher, J ;
Levin, H ;
Zippe, C ;
Klein, E .
UROLOGY, 1996, 48 (02) :249-260
12345